Arbutus Biopharma Corporation Common Stock (NASDAQ: ABUS) last traded at $5.21, up 9.22% on the session. The quote above updates while this page is open; the figures below are drawn from Arbutus Biopharma Corporation Common Stock’s own filings and are restated only when a new one is published.
Arbutus Biopharma Corporation Common Stock trades on NASDAQ under the ticker ABUS. Its market capitalisation is $1.03 billion.
Valuation measures for Arbutus Biopharma Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.03B |
|---|---|
| Enterprise value | $1.03B |
| P/E ratio | 6.59 |
| Price / sales | 5.67 |
| Price / book | 3.98 |
| Beta | 1.26 |
Trailing-twelve-month figures tagged in Arbutus Biopharma Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $181.72M |
|---|---|
| Net income (TTM) | $153.05M |
| EPS (TTM) | $0.790 |
| Operating margin | 81.99% |
| Return on equity | 59.16% |
| Cash | $19.17M |
Range and volume for ABUS over the past 52 weeks.
| 52-week high | $5.45 |
|---|---|
| 52-week low | $3.49 |
| Volume | 18.05M |
| Average volume | 2.26M |
| Previous close | $4.77 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.